SEC Company Response from TANDEM DIABETES CARE INC (TNDM) (CIK 0001438133) (TNDM) — Mar 21, 2017
TANDEM DIABETES CARE INC (TNDM) (CIK 0001438133)
Date: March 21, 2017 · CIK: 0001438133 · Accession: 0001193125-17-089974
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-216531
Letter
PIPER JAFFRAY & CO.
800 Nicollet Mall
Minneapolis, Minnesota 55402
March 20, 2017
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C.
Re: Tandem Diabetes Care, Inc.
Registration Statement on Form S-1 (File No. 333-216531)
Ladies and Gentlemen:
In connection with the above-referenced Registration Statement, and pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), we hereby join in the request of Tandem Diabetes Care, Inc. that the effective date of the above-referenced Registration Statement be accelerated so that it will be declared effective at 4:00 p.m., Eastern Time, on March 22, 2017 or as soon thereafter as practicable.
The following is supplemental information supplied under Rule 418(a)(7) and Rule 460 under the Act:
(i) Dates of distribution: March 20, 2017 through the date hereof.
(ii) Number of prospectuses distributed: a total of approximately 250 copies were distributed to prospective underwriters, institutional investors, dealers and others.
(iii) We have been informed by the participating underwriters that they have complied and will comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934.
[SIGNATURE PAGE FOLLOWS]
Very truly yours,
PIPER JAFFRAY & CO.
Show Raw Text
CORRESP 1 filename1.htm CORRESP PIPER JAFFRAY & CO. 800 Nicollet Mall Minneapolis, Minnesota 55402 March 20, 2017 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Tandem Diabetes Care, Inc. Registration Statement on Form S-1 (File No. 333-216531) Ladies and Gentlemen: In connection with the above-referenced Registration Statement, and pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), we hereby join in the request of Tandem Diabetes Care, Inc. that the effective date of the above-referenced Registration Statement be accelerated so that it will be declared effective at 4:00 p.m., Eastern Time, on March 22, 2017 or as soon thereafter as practicable. The following is supplemental information supplied under Rule 418(a)(7) and Rule 460 under the Act: (i) Dates of distribution: March 20, 2017 through the date hereof. (ii) Number of prospectuses distributed: a total of approximately 250 copies were distributed to prospective underwriters, institutional investors, dealers and others. (iii) We have been informed by the participating underwriters that they have complied and will comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934. [SIGNATURE PAGE FOLLOWS] Very truly yours, PIPER JAFFRAY & CO. As Representative of the Underwriters PIPER JAFFRAY & CO. By: /s/ Christie L. Christina Name: Christie L. Christina Title: Managing Director Piper Jaffray & Co. [Signature Page to Acceleration Request]